HCA Midwest Health - November 27, 2017

When you hear the word cancer in a diagnosis, your first plan of action might be to delve into the latest research on treating the disease, but studying medical information can be a lengthy and complicated process.

HCA Midwest Health is part of the Sarah Cannon Cancer Network That connects us to a research network that has been conducting community-based clinical trials for more than 20 years, and has been a clinical trial leader in approximately 80 percent of approved cancer therapies over the last 10 years. With more than 500 clinical trials available, Sarah Cannon provides patients with many types of options, including immunotherapies and other targeted medicines currently under investigation. Through our network, we stay abreast of the latest research. Our goal is to focus on treating our patients with the best care for their disease and offering the newest standards when recommending care plans.

Our patients have the options to get the best treatment for their condition and also to have access to clinical trials that may help their condition or advance the understanding of their disease. We have the treatment you need, with the compassionate care you deserve—all without having to leave your community. For more information or answers to your cancer-related questions call askSARAH at (816) 448-7737 to speak with a registered nurse.

Learn more about clinical trials by watching the video below.

tags: cancer care , t4b